Skip to content

Role of Individualised Homoeopathic medicine in cases of Dementia

Role of Individualised Homoeopathic Medicine in cases of Dementia in the age group of 50-80 years based on Kent’s Repertory: An Open Label Observational Clinical Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064583
Enrollment
40
Registered
2024-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F015- Vascular dementia Health Condition 2: F028- Dementia in other diseases classified elsewhere Health Condition 3: F039- Unspecified dementia

Interventions

Intervention1: Individulised Homoeopathic Medicine: a)Cognitive function of patient will be first assessed at 1st Visit i.e. baseline using MoCA test b) Individualised Homoeopathic Medicine will be se

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having symptoms of dementia. 2. Patient willing to participate in the study after submitting their written informed consent forms. 3. Patient of both gender and all religion. 4. Patient belonging to age group of 50 to 80 years. 5. Patient must know either of the 3 languages- Bengali, Hindi or English. 6. Lifesaving conventional drug therapies (e.g., antidiabetics, antihypertensives, thyroid drugs, etc.) for comorbidities under control, to be continued uninterrupted.

Exclusion criteria

Exclusion criteria: 1. Currently receiving homoeopathic treatment for any chronic condition(s). 2. Diagnosed cases of unstable mental or psychiatric illness or other systemic disease affecting quality of life. 3. Uncontrolled, unevaluated, and/or complicated diabetes mellitus, hypertension, and other comorbidities; cases with other serious systemic unevaluated or uncontrolled diseases affecting quality of life. 4. Substance abuse and/or dependence. 5. Self-reported immune-compromised state.

Design outcomes

Primary

MeasureTime frame
To observe the change in the score of Montreal Cognitive Assessment (MoCA) over 6 months from baselineTimepoint: Baseline and after 6 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Birendra Prasad Srivastava

National Institute of Homoeopathy

dr.srivastava61@gmail.com7003178867

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026